1. Introduction
Xanthine oxidoreductase (XOR) is a ubiquitous uric acid (UA)-producing enzyme that catalyzes the oxidation of hypoxanthine to xanthine [
1,
2,
3] and is the total activity of both xanthine dehydrogenase (XDH) and xanthine oxidase (XO) [
4,
5,
6]. XDH reduces nicotinamide adenine dinucleotide, and XO consumes oxygen to produce superoxide (O
2−) [
1,
5,
6].
XOR activity and nicotinamide adenine dinucleotide phosphatase (NADPH) oxidase promote an increase in O
2− and is recognized as a significant source of reactive oxygen species (ROS) [
5,
7,
8], contributing to the development of oxidative stress-related tissue injury [
2,
5,
6,
7,
8]. An increase in XOR activity has been reported to be related to the development of various diseases, such as metabolic disorders and heart failure (HF) [
9,
10,
11,
12]. It has also been reported that XOR activity is involved in vascular inflammation and then the development of atherosclerosis [
13]. In addition, NADPH oxidase plays an important role in atherosclerosis via ROS [
7,
8]. However, the association between XOR activity and the risk for cardiovascular disease (CVD), such as the Framingham Risk Score (FRS), has been uncertain in a general Japanese population.
The purpose of this study was to investigate the association between XOR activity and a high risk of CVD in a general Japanese population.
2. Materials and Methods
2.1. Study Population
The present study included 1737 participants (males/females = 577/1160) who participated in this study as part of a general population-based cohort study designed by the Iwate Tohoku Medical Megabank Organization (TMM). The participants were aged 20 years or older and completed self-administered questionnaires covering a wide range of topics, including sociodemographic factors, lifestyle habits, and a self-reported medical history. A history of hyperuricemia was defined based on the self-reported medical history. Blood samples were collected by experienced nurses. Participants were excluded from the study if they had a history of hyperuricemia, stroke, coronary artery disease (CAD), HF, or a malignant or primary wasting disorder.
In accordance with the Declaration of Helsinki (1991), written informed consent was obtained from each subject. This study was approved by the Ethics Committee of Iwate Medical University (HGH29-4).
2.2. Cohort Data Collection
All participants completed self-administered questionnaires and underwent standardized interviews conducted by trained research staff who collected information about medical history and medication. Blood samples and random spot urine samples were collected.
Hypertension was defined as systolic blood pressure (SBP) ≥140 mmHg, diastolic blood pressure (DBP) ≥90 mmHg, having been diagnosed with hypertension, and/or the use of antihypertensive medication [
14]. Diabetes was defined as a glycated hemoglobin (HbA1c) value ≥6.5%, a non-fasting glucose concentration ≥200 mg/dL, having been diagnosed with diabetes, and/or undergoing treatment with antidiabetic drugs including insulin [
15]. Dyslipidemia was defined as a low-density lipoprotein (LDL) cholesterol ≥140 mg/dL, having been diagnosed with dyslipidemia, and/or the use of antihyperlipidemic medication [
16].
2.3. Measurements of XOR Activity
Plasma XOR activity was measured using frozen samples that were maintained at −80 °C until the time of assay and was measured using the recently established assay using stable isotope-labelled [13C2,15N2] xanthine with liquid chromatography mass spectrometry (Nano Space SI-2 LC system, Shiseido, Tokyo, Japan) and a TSQ-Quantum triple quadrupole mass spectrometer (Thermo Fisher Scientific GmbH, Bremen, Germany) [
17,
18]. The calibration curve of [13C2,15N2] UA showed linearity over the range of 4–4000 nM (r
2 > 0.995) with a lower limit of quantitation of 4 nM. The lower detection limit of XOR activity was 6.67 pmol/h/mL plasma, and intra- and inter-assay coefficients of variation of human plasma XOR activity were 6.5% and 9.1%, respectively [
17].
2.4. Framingham Risk Score
The FRS includes gender, age, total cholesterol value, HDL-cholesterol value, SBP, presence or absence of diabetes, and the presence or absence of smoking [
19]. The FRS can predict the development of ischemic heart disease within 10 years [
19]. In this study, we classified a high risk of CVD when FRS was ≥15 based on a previous study [
20].
2.5. Statistical Analysis
Numeric variables are presented as mean ± standard deviation (SD) for normal distribution and median (interquartile range) for skewed variables. Categorical data are presented as frequencies and percentages. Student’s t-test for continuous variables that exhibited a normal distribution, Mann–Whitney U test for continuous variables with skewed variables, and a chi-square test for categorical variables were used to evaluate differences in characteristics. Non-normally distributed parameters were logarithmically transformed for the analysis. The correlation between two variables was evaluated using Pearson’s correlation coefficient. We performed multiple regressions to identify independent determinants of XOR activity using age, gender, and the variables with significance after consideration of multicollinearity. Additionally, the distribution of XOR activity was confirmed and classified into quartiles. The basic attributes were compared among the four groups by using analysis of variance (ANOVA) for normal distribution and the Kruskal–Wallis test for skewed variables. Additionally, we performed a logistic regression to identify the association between XOR activity and a high risk for CVD, and we obtained receiver operating characteristic (ROC) curves to examine the strength of the correlation between a high risk of CVD and XOR activity. All data were analyzed using IBM SPSS Statistics version 25 for Windows (IBM Corp., Armonk, NY, USA). Differences of p < 0.05 were considered statistically significant.
4. Discussion
The present study investigated the association between XOR activity and a high risk for CVD in a general Japanese population. XOR activity was significantly and independently associated with BMI, diabetes, dyslipidemia, and UA. In addition, XOR activity was strongly related to a high risk of CVD. To the best of our knowledge, this is the first study to reveal the association between XOR activity and the risk of CVD in the general Japanese population.
Our study showed a significant difference in XOR activity between males and females. Similar to our study, a previous study on the general Japanese population found higher XOR activity in males than in females [
12]. Baseline characteristics showed significant differences in laboratory data and the prevalence of smoking and medical history between males and females. It has therefore been suggested that the gender difference of XOR activity may be related to the prevalence of smoking and medical history, including hypertension, diabetes, and dyslipidemia.
Multiple regression analyses showed that XOR activity was independently associated with the presence of diabetes and dyslipidemia. In addition, XOR activity was positively correlated with UA and HbA1c levels. It has been reported that XOR activity is positively correlated with HbA1c in diabetic patients [
21]. Furuhashi et al., in their study on a general Japanese population, reported that XOR activity was associated with dyslipidemia [
12]. An elevated XOR activity is responsible for the formation of UA from hypoxanthine and xanthine, leading to O
2− and ROS production [
4,
22]. It is well known that ROS production in the vessel wall is involved in the progression of arteriosclerosis [
23]. XOR activity generates ROS and causes endothelial dysfunction [
2,
3,
6,
24,
25,
26]. In addition, XOR activity has been known to reflect the degree of progression of arteriosclerosis [
2,
3]. A study on outpatients with CVD also reported that higher XOR activity was independently associated with diabetes [
27]. These observations suggest that the presence of diabetes and dyslipidemia may induce ROS production via elevated XOR activity and then be related to the progression of atherosclerosis.
The present study showed that XOR activity was positively correlated with BMI. It has been demonstrated before that XOR activity is correlated with obesity [
3]. An experimental study has previously shown that adipose tissues in obese mice have higher XOR activities than control mice [
8]. In addition, adipose tissue is an important determinant of the chronic inflammatory state, as reflected by levels of proinflammatory cytokines, suggesting a link between the latter and obesity and CVD [
28]. It has also been reported that XOR activity is positively correlated with BMI and subclinical inflammation in young humans [
29]. These observations suggest that adiposity is closely associated with XOR activity and is involved in the progression of CVD through vascular inflammation.
The FRS is a common tool for predicting the likelihood of developing CVD in the long term, and a high FRS indicates a high risk of future CVD events [
19]. Our results showed that elevated XOR activity was significantly related to high FRS, indicating a high risk for CVD. In addition, the AUC was 0.81 (95% CI = 0.66–0.97), suggesting a high predictive and diagnostic ability of XOR as the biomarker for the risk of CVD. NADPH oxidase and XOR activities contribute to the generation of ROS and oxidative stress-related tissue damage [
2,
5,
6,
7,
8], leading to the development of CVD [
6]. From these observations, it has been speculated that XOR activity may serve as a new biomarker for predicting future CVD.
There are a few limitations to this study while interpreting our results. First, only a baseline measurement of XOR activity and other covariates was performed because this was a cross-sectional study. Second, this study evaluated whether each participant had CVD using a self-reported questionnaire rather than clinical examination. A future prospective study is needed to determine whether XOR activity is an independent predictor of long-term cardiovascular outcomes. Third, although NADPH oxidase plays an important role in oxidative stress and progression of atherosclerosis [
7,
8], the present study did not measure NADPH oxidase levels owing to a lack of funds and samples.